Skip to content

Clinical equivalence study of two brands of polyester sutures (Trubond® and Ethibond) for fixation of the valvular prosthesis, in subjects undergoing aortic or mitral valve replacement

Single blind, randomized study evaluating clinical equivalence of Trubond® vs Ethibond® braided polyester suture for fixation of the valvular prosthesis, using interrupted suture technique, in subjects undergoing aortic or mitral valve replacement

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/04/024608
Enrollment
88
Registered
2020-04-14
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Trubond® braided polyester suture: Braided polyester suture of Healthium Medtech Private Limited, used for fixation of the valvular prosthesis, using interrupted suture technique, in s

Sponsors

Healthium Medtech Pvt Ltd formerly Sutures India Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects aged >=18 or 2. Subjects eligible for implantation of aortic or mitral valve through open heart surgery 3. Subjects who have given written informed consent

Exclusion criteria

Exclusion criteria: 1. Subjects requiring multi-valve surgery 2. Subjects with a history of CABG or any valve surgery 3. Pregnancy and women of childbearing potential having positive urine pregnancy test prior to enrollment 4. Subjects with implanted pacemaker 5. Subjects with implantable cardiac defibrillator 6. Subjects with history of allergy to polyester or similar products 7. Subjects already participating in another surgical study 8. Subjects with history of bleeding disorders 9. Subjects who had the habit of drug abuse 10. Subjects who received an experimental drug or used an experimental medical device within 30 days prior to the planned start of procedure 11. Subjects unlikely to comply with surgical procedure or complete the scheduled follow up visit, in the opinion of investigator 12. Employees of the investigator or study center with direct involvement in the proposed study or other studies under the direction of that investigator or study center 13. Subjects with mental disorder, learning disability, or language barrier 14. Other indication-based exclusion, in opinion of investigator

Design outcomes

Primary

MeasureTime frame
1. To assess the event rate of paravalvular leakage in both the groups.Timepoint: within 26 weeks of index surgery

Secondary

MeasureTime frame
1. To assess the event rate of major adverse events (including death, stroke, myocardial infarction and surgical reintervention) in two groups 2. To evaluate tissue reaction, material problems and other adverse events among the two groups. 3.To evaluate postoperative discomfort and overall subject satisfaction score in both the groups Timepoint: within 26 weeks of index surgery

Countries

India

Contacts

Public ContactDr Ashok Kumar Moharana

Healthium Medtech Pvt.Ltd.

ashok.m@healthiummedtech.com9717887751

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026